Scinovex
article Open AccessTop 1% cited

Antithrombotic Therapy for Atrial Fibrillation

CHEST Journal · 2018 · Vol. 154(5) · pp. 1121–1201
Gregory Y.H. LipAmitava BanerjeeGiuseppe BorianiChern En ChiangRamiz FargoBen FreedmanDeirdre A. LaneChristian T. RuffMintu P. TurakhiaDavid J. WerringSheena PatelLisa K. Moores
Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsAntiplatelet Therapy and Cardiovascular DiseasesAntithromboticAtrial fibrillationCardiologyMedicineInternal medicineFibrinolytic agentIntensive care medicine

MeSH terms

AgedAnticoagulantsAtrial FibrillationClinical ProtocolsFibrinolytic AgentsHumansThromboembolismWarfarinRisk AssessmentStroke

Funding

  • Bristol-Myers Squibb
  • Pfizer
  • AstraZeneca
  • Bayer
  • GlaxoSmithKline
  • Gilead Sciences
  • Bayer HealthCare
  • Daiichi-Sankyo
  • Servier
  • St. Jude Medical
Citations
924
FWCI
87.02
field-weighted impact
References
613
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.